New Obesity Drug Increases Sensitivity to Leptin

by Kathy Jones on  July 27, 2012 at 10:30 PM Obesity News
RSS Email Print This Page Comment bookmark
Font : A-A+

A new study published in the journal Cell Metabolism reveals the development of a new obesity drug that increases sensitivity to a hormone which regulates hunger.
 New Obesity Drug Increases Sensitivity to Leptin
New Obesity Drug Increases Sensitivity to Leptin

Known as JD5037, the drug is similar to rimonabant which was banned in 2008 both in the United States and Europe after it was linked with increased risk of depression and suicide.

The drug works by increasing the body's sensitivity to a hormone known as leptin, which is a naturally occurring appetite suppressant in the body. The researchers found that the drug not only increased leptin's sensitivity but also regulated the hormone levels in a range similar to that found in a lean body shape.

"By sensitizing the body to naturally occurring leptin, the new drug could not only promote weight loss, but also help maintain it. This finding bodes well for the development of a new class of compounds for the treatment of obesity and its metabolic consequences", lead researcher George Kunos said.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Bariatric Surgery Drug Toxicity Obesity Diabetes - Essentials Binge Eating : The Pleasure and Pain Bulimia Nervosa Body Mass Index Signature Drug Toxicity Liposuction Battle of the Bulge 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive